COMPARISON OF THE EFFICACY AND SAFETY OF CALCINEURIN INHIBITOR CONVERSION TO mTOR INHIBITOR AND CNI MINIMIZATION IN KIDNEY TRANSPLANTS WITH CHRONIC ALLOGRAFT NEPHROPATHY

被引：0
|
作者：
Rojsanga, Piyarat [1 ]
Vongwiwatana, Attapong [1 ]
Premasathian, Nalinee [1 ]
Vasuvattakul, Somkiat [1 ]
机构：
[1] Mahidol Univ, Siriraj Hosp, Div Nephrol, Dept Med, Bangkok 10700, Thailand
来源：
TRANSPLANT INTERNATIONAL | 2011年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：300 / 300
页数：1
相关论文
共 50 条
  • [1] Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy
    Falger, Jutta C.
    Mueller, Thomas
    Arbeiter, Klaus
    Boehm, Michael
    Regele, Heinz
    Balzar, Egon
    Aufricht, Christoph
    [J]. PEDIATRIC TRANSPLANTATION, 2006, 10 (04) : 474 - 478
  • [2] Conversion from calcineurin inhibitor to sirolimus in pediatric chronic allograft nephropathy
    Falger, Jutta C.
    Mueller, Thomas
    Arbeiter, Klaus
    Boehm, Michael
    Regele, Heinz
    Balzar, Egon
    Aufricht, Christoph
    [J]. PEDIATRIC TRANSPLANTATION, 2006, 10 (05) : 565 - 569
  • [3] Observation of efficacy and safety of converting the calcineurin inhibitor to sirolimus in renal transplant recipients with chronic allograft nephropathy
    Chen, J.
    Li, L.
    Wen, J.
    Tang, Z.
    Ji, S.
    Sha, G.
    Cheng, Z.
    Sun, Q.
    Cheng, D.
    Liu, Z.
    [J]. TRANSPLANTATION PROCEEDINGS, 2008, 40 (05) : 1411 - 1415
  • [4] Conversion to Sirolimus for Chronic Allograft Nephropathy and Calcineurin Inhibitor Toxicity and the Adverse Effects of Sirolimus After Conversion
    Sayin, B.
    Karakayali, H.
    Colak, T.
    Sevmis, S.
    Pehlivan, S.
    Demirhan, B.
    Haberal, M.
    [J]. TRANSPLANTATION PROCEEDINGS, 2009, 41 (07) : 2789 - 2793
  • [5] Impact of Calcineurin-Inhibitor Conversion to mTOR Inhibitor on Renal Allograft Function in a Prednisone-Free Regimen
    Chhabra, D.
    Alvarado, A.
    Dalal, P.
    Leventhal, J.
    Wang, C.
    Sustento-Reodica, N.
    Najafian, N.
    Skaro, A.
    Levitsky, J.
    Mas, V.
    Gallon, L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 (11) : 2902 - 2911
  • [6] Improvement of chronic allograft nephropathy by reduction of calcineurin inhibitor and introduction of mycophenolic acid
    Merkel, Saskia
    Mengel, Michael
    Haller, Hermann
    Schwarz, Anke
    [J]. TRANSPLANT INTERNATIONAL, 2007, 20 : 238 - 238
  • [7] An mTOR-inhibitor-based protocol and calcineurin inhibitor (CNI)-free treatment in kidney transplant recipients from donors after cardiac death: good renal function, but high incidence of conversion to CNI
    Sanchez-Escuredo, Ana
    Diekmann, Fritz
    Revuelta, Ignacio
    Esforzado, Nuria
    Jose Ricart, Maria
    Cofan, Frederic
    Torregrosa, Jose-Vicente
    Peri, Lluis
    Ruiz, Angel
    Maria Campistol, Josep
    Oppenheimer, Federico
    [J]. TRANSPLANT INTERNATIONAL, 2016, 29 (03) : 362 - 368
  • [8] Conversion from calcineurin-inhibitor (CNI) based immunosuppression to Sirolimus in chronic CNI toxicity after renal transplantation
    Diekmann, F
    Waiser, J
    Einecke, G
    Dragun, D
    Fritsche, L
    Neumayer, HH
    Budde, K
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 : 364A - 364A
  • [9] Predictors of success in conversion from calcineurin inhibitor to sirolimus in chronic allograft dysfunction
    Diekmann, F
    Budde, K
    Oppenheimer, F
    Fritsche, L
    Neumayer, HH
    Campistol, JM
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (11) : 1869 - 1875
  • [10] Comparison of efficacy and safety of sirolimus(SLR) and mycophenolate mofetil(MMF) as adjunct to calcineurin inhibitor(CNI) based steroid free immunosuppression in kidney transplantation.
    Kumar, MSA
    Fyfe, B
    Sierka, D
    Heifets, M
    Saeed, MI
    Parikh, MH
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 578 - 578
12345